| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $30.35B | $27.75B | $28.26B |
| YoY Revenue Growth % | +9.4% | -1.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.84B | $2.42B | $384.0M |
| Operating Margin % | 6.1% | 8.7% | 1.4% |
| Net Income (GAAP) | $864.0M | $1.13B | -$202.0M |
| EBITDA (Normalized) | $2.76B | $2.80B | $1.40B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.91B | $2.31B | -$221.0M |
| Capital Expenditures (CapEx) | $1.15B | $472.0M | $1.27B |
| Free Cash Flow (FCF) | $766.0M | $1.83B | -$1.49B |
| FCF Margin % | 2.5% | 6.6% | -5.3% |
| Return on Invested Capital (ROIC %) | 10.9% | 16.9% | 1.5% |
| Cash & Short-Term Equivalents | $4.71B | $966.0M | — |
| Total Debt (Short + Long Term) | $16.41B | $9.81B | $7.93B |
| Total Stockholders' Equity | $1.68B | $2.48B | $16.28B |